FDANonrulemakingFDA-2017-N-2936

Who commented on this docket

Content of Risk Information in the Major Statement in Prescription Drug Direct-to-Consumer Broadcast Advertisements; Request for Information and Comments

7 organizations filed 7 public comments on Content of Risk Information in the Major Statement in Prescription Drug Direct-to-Consumer Broadcast Advertisements; Request for Information and Comments, at the Food and Drug Administration. The comment window closed 3172d ago.

Organizations
7
Comments
7
RIN
Comment window
closed 3172d ago

Commenters (7)

  • Coalition for Healthcare Communicationtrade assoc.
    1 filing · confidence 85%
  • Eli Lilly and Companyunverified attribution
    1 filing · confidence 70%
  • Gilead Sciences Inc.unverified attribution
    1 filing · confidence 70%
  • National Association of Broadcasterstrade assoc.
    1 filing · confidence 85%
  • Pharmaceutical Care Management Associationtrade assoc.
    1 filing · confidence 85%
  • The Association of Magazine Mediatrade assoc.
    1 filing · confidence 85%
View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.